Immune Checkpoint Inhibitors With or Without Bone-Targeted Therapy in NSCLC Patients With Bone Metastases and Prognostic Significance of Neutrophil-to-Lymphocyte Ratio

INTRODUCTION: Bone metastases (BMs) are a negative prognostic factor in patients with non-small cell lung cancer (NSCLC). Although immune-checkpoint inhibitors (ICIs) have dramatically changed the therapeutic landscape of NSCLC, little information is available on BMs from NSCLC treated with ICIs alo...

Descripción completa

Detalles Bibliográficos
Autores principales: Bongiovanni, Alberto, Foca, Flavia, Menis, Jessica, Stucci, Stefania Luigia, Artioli, Fabrizio, Guadalupi, Valentina, Forcignanò, Maria Rosachiara, Fantini, Manuela, Recine, Federica, Mercatali, Laura, Spadazzi, Chiara, Burgio, Marco Angelo, Fausti, Valentina, Miserocchi, Anna, Ibrahim, Toni
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8631508/
https://www.ncbi.nlm.nih.gov/pubmed/34858389
http://dx.doi.org/10.3389/fimmu.2021.697298

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8631508/
https://www.ncbi.nlm.nih.gov/pubmed/34858389
http://dx.doi.org/10.3389/fimmu.2021.697298

Ejemplares similares